Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMPrEP Amsterdam PrEP demonstration project
NL-OMON22706Active, not recruiting
- Sponsor
- Academic Medical Center is sponsor. Center for study visits: Public Health service Amsterdam (GGD Amsterdam)
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Academic Medical Center is sponsor. Center for study visits: Public Health service Amsterdam (GGD Amsterdam). Primary endpoints: Uptake of comprehensive HIV prevention program, Acceptability of intervention strategy and 1 more. Started Aug 2015; status: active, not recruiting.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NL-OMON22706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22706.